VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Amgen Inc. vs The Campbell's Company
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Amgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
The Campbell's Company
CPB · The Nasdaq Stock Market LLC
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into The Campbell's Company's moat claims, evidence, and risks.
View CPB analysisComparison highlights
- Moat score gap: Amgen Inc. leads (70 / 100 vs 61 / 100 for The Campbell's Company).
- Segment focus: Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines); The Campbell's Company has 2 segments (59% in Meals & Beverages).
- Moat breadth: Amgen Inc. has 5 moat types across 3 domains; The Campbell's Company has 3 across 2.
Primary market context
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
The Campbell's Company
Meals & Beverages
Branded shelf-stable meals, soup/broth, sauces and beverages (retail + foodservice)
U.S. and Canada
Retailers, foodservice distributors, and end-consumers
Branded food manufacturer (CPG)
59%
Side-by-side metrics
Moat coverage
Shared moat types
Amgen Inc. strengths
The Campbell's Company strengths
Segment mix
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
The Campbell's Company segments
Full profile >Meals & Beverages
Competitive
Snacks
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.